Cardiovascular and metabolic findings in elite athletes undergoing screening for Milano-Cortina 2026 Winter Olympic Games: insights from the Italian Olympic Screening Program
Medicina dello Sport · 01.01.2026 · 79 (1)
DOI: 10.1728/4733.47493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina dello Sport, erschienen am 01.01.2026. Verfasst von Maria Rosaria Squeo und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Although pre-participation screening (PPS) has been extensively studied in summer Olympic athletes, data on winter Olympic disciplines remain limited. The aim of the study is to evaluate cardiovascular and cardiometabolic abnormalities in elite athletes selected for the Milano-Cortina 2026 Winter Olympic Games and to compare these findings with previous Olympic cohorts.
Methods
Athletes who were candidates for the Milano-Cortina 2026 Winter Olympic Games underwent a comprehensive multidisciplinary PPS evaluation including medical history, ECG, echocardiography, cardiopulmonary exercise testing and full blood analysis. Athletes were classified according to ESC (skill, power, mixed, endurance). Additional investigations were performed when clinically indicated.
Results
340 athletes were enrolled (43.2% female, mean age 26.8±0.3 years). 65 (19.1%) showed cardiovascular abnormalities at first-level screening. Exercise-induced arrhythmias represented the most frequent abnormality (60%), followed by ECG and echocardiographic alterations. After second-level evaluation, cardiovascular alterations were established in 31 athletes (47.7% of those with initial abnormalities), including atrial dilation, aortic root dilation, valvular abnormalities, borderline QT prolongation, and myocardial scar. Only one athlete (0.3% of the total cohort) was deemed not eligible for competitive sport due to extensive myocardial scar associated with arrhythmias. Regarding cardiometabolic profile, 79 athletes (23.2%) exhibited abnormal values, predominantly isolated hypercholesterolemia (77.2%).
Conclusions
Olympic winter athletes are not exempt from cardiovascular and metabolic conditions. The implementation of an advanced, multidisciplinary PPS protocol enabled the identification of clinically relevant abnormalities that could impact both athlete safety and performance. These findings highlight the importance of tailored screening strategies in winter sports and support the role of comprehensive cardiovascular evaluation in Olympic athletes.
Zitieren
APA
Squeo, M. R., Ferrera, A., Serdoz, A., Mango, F., Maestrini, V., Spinelli, A., Fiore, R., Paolettio, G., Spera, F. R., Ginelli, D., Macori, L., Spada, R., Pelliccia, A., & Gioia, G. D. (2026). Cardiovascular and metabolic findings in elite athletes undergoing screening for Milano-Cortina 2026 Winter Olympic Games: insights from the Italian Olympic Screening Program. Medicina dello Sport, 79(1). https://doi.org/10.1728/4733.47493
Vancouver
Squeo MR, Ferrera A, Serdoz A, Mango F, Maestrini V, Spinelli A, et al. Cardiovascular and metabolic findings in elite athletes undergoing screening for Milano-Cortina 2026 Winter Olympic Games: insights from the Italian Olympic Screening Program. Medicina dello Sport. 2026;79(1). doi:10.1728/4733.47493
BibTeX
@article{Squeo2026,
author = {Squeo, Maria Rosaria and Ferrera, Armando and Serdoz, Andrea and Mango, Federica and Maestrini, Viviana and Spinelli, Alessandro and Fiore, Roberto and Paolettio, Giulia and Spera, Francesco Raffaele and Ginelli, Daniele and Macori, Lucrezia and Spada, Raffaella and Pelliccia, Antonio and Gioia, Giuseppe Di},
title = {Cardiovascular and metabolic findings in elite athletes undergoing screening for Milano-Cortina 2026 Winter Olympic Games: insights from the Italian Olympic Screening Program},
journal = {Medicina dello Sport},
year = {2026},
volume = {79},
number = {1},
doi = {10.1728/4733.47493}
}
EUVIMED